Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05119842 · ClinicalTrials.gov registry record · NA
APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study
A NA study of Paralysis, Unilateral, Vocal Cord, sponsored by APrevent Biotech.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 7
- Study locations
NCT05119842 is a NA study of Paralysis, Unilateral, Vocal Cord that is actively recruiting participants, run by APrevent Biotech. The registered enrollment target is 30 participants. The trial reports 7 study locations across 5 states.
The verdict
NCT05119842, a NA study of Paralysis, Unilateral, Vocal Cord, is actively recruiting participants, sponsored by APrevent Biotech.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a prospective, 2-part, multi-center, open-label, non-randomized clinical trial to assess safety and effectiveness of APrevent® VOIS Implants for the treatment of patients with Unilateral Vocal Fold Paralysis (UVFP). In total 30 evaluable patients are planned to be enrolled.
Conditions Studied
Interventions
- DEVICE APrevent® VOIS-Implant
Study Locations (7)
Other
- Medical University of Vienna - Vienna
- SRH Wald-Klinikum Gera - Gera
- University Medical Center - Hamburg
Arizona
- Mayo Clinic - Phoenix - Phoenix
Maryland
- Greater Baltimore Medical Center - Baltimore
Ohio
- Cleveland Clinic - Cleveland
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05119842
The ClinicalTrials.gov registry entry for NCT05119842 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is APrevent Biotech, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paralysis, Unilateral, Vocal Cord appearing as the primary indexed condition, and to 1 intervention - of which APrevent® VOIS-Implant is the first listed.
NCT05119842 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Other, Arizona, Maryland.
Frequently Asked Questions
What is clinical trial NCT05119842 about?
NCT05119842 is a clinical study titled "APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study". This is a prospective, 2-part, multi-center, open-label, non-randomized clinical trial to assess safety and effectiveness of APrevent® VOIS Implants for the treatment of patients with Unilateral Vocal Fold Paralysis (UVFP). In total 30 evaluable patients are planned to be enrolled.
What is the current status of trial NCT05119842?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2019-11-13. Estimated completion is 2026-09.
What conditions does trial NCT05119842 study?
This clinical trial studies the following conditions: Paralysis, Unilateral, Vocal Cord.
What interventions are being tested in trial NCT05119842?
The interventions under investigation include: APrevent® VOIS-Implant (DEVICE).
Who is sponsoring clinical trial NCT05119842?
This trial is sponsored by APrevent Biotech, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05119842 being conducted?
This trial has 7 study locations across Arizona, Maryland, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.